NCT05316025

Brief Summary

The COVID-19 health crisis has led to a drastic decrease in the rate of myocardial infarction without the causes being completely identified. They are probably multiple, but this crisis has confirmed the need for massive health data from different horizons to better assess coronary disease in order to develop precision medicine. This objective is now achievable thanks to the use of tools such as big data and artificial intelligence (AI). Our team is developing algorithms to analyze medical images and identify people at risk of major cardiovascular events. These algorithms which are developed with retrospective data must be validated on prospective data, which is the objective of the Grenoble cardiovascular digital health data observatory. The algorithm that will be validated is currently being created as part of a RIPH 3 study "AIDECORO" (NCT: 04598997). It is being developed from clinical, biological and imaging data from 600 patients with ST+ infarction and 1000 "control" patients who have undergone coronary angiography (these data are exported and stored in the PREDIMED health data warehouse via the hospital information system).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 7, 2022

Completed
24 days until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

April 7, 2022

Status Verified

January 1, 2022

Enrollment Period

2.7 years

First QC Date

February 3, 2022

Last Update Submit

March 29, 2022

Conditions

Keywords

Deep learningObservatoryCardiovascularHealth data

Outcome Measures

Primary Outcomes (1)

  • Prospectively validate cardiovascular medical image analysis algorithms capable of identifying patients with poor prognostic criteria using artificial intelligence and big data methods.

    The rate of occurrence of death or hospitalization for heart failure during follow-up.

    Through study completion, an average of 1 year

Secondary Outcomes (8)

  • Evaluate the predictive performance of algorithms to identify patients with persistent anginal symptoms.

    12 months

  • Evaluate the predictive performance of algorithms to identify patients with persistent dyspnea symptoms.

    12 months

  • Evaluate the predictive performance of algorithms to identify patients with good disease perception.

    12 months

  • Evaluate the predictive performance of algorithms to identify patients satisfied with their care.

    12 months

  • Evaluate the predictive performance of the algorithms for quality of life at one year.

    12 months

  • +3 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients receiving coronary angiography during hospitalization for suspected or managed coronary artery disease at CHUGA.

You may qualify if:

  • Adult patients who have undergone coronary angiography at CHUGA for whom images are usable.
  • No opposition to participation

You may not qualify if:

  • Coronary image not usable
  • Persons referred to in articles L1121-5 to L-1121-8 of the CSP
  • Patients living outside the Rhône Alpes region.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestol K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet. 2020 Feb 1;395(10221):350-360. doi: 10.1016/S0140-6736(19)32998-8.

    PMID: 32007170BACKGROUND
  • Gonzalez G, Ash SY, Vegas-Sanchez-Ferrero G, Onieva Onieva J, Rahaghi FN, Ross JC, Diaz A, San Jose Estepar R, Washko GR; COPDGene and ECLIPSE Investigators. Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography. Am J Respir Crit Care Med. 2018 Jan 15;197(2):193-203. doi: 10.1164/rccm.201705-0860OC.

    PMID: 28892454BACKGROUND
  • Lu MT, Ivanov A, Mayrhofer T, Hosny A, Aerts HJWL, Hoffmann U. Deep Learning to Assess Long-term Mortality From Chest Radiographs. JAMA Netw Open. 2019 Jul 3;2(7):e197416. doi: 10.1001/jamanetworkopen.2019.7416.

    PMID: 31322692BACKGROUND
  • Betancur J, Hu LH, Commandeur F, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Germano G, Otaki Y, Liang JX, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study. J Nucl Med. 2019 May;60(5):664-670. doi: 10.2967/jnumed.118.213538. Epub 2018 Sep 27.

    PMID: 30262516BACKGROUND
  • Slama R, Morgenstern V, Cyrys J, Zutavern A, Herbarth O, Wichmann HE, Heinrich J; LISA Study Group. Traffic-related atmospheric pollutants levels during pregnancy and offspring's term birth weight: a study relying on a land-use regression exposure model. Environ Health Perspect. 2007 Sep;115(9):1283-92. doi: 10.1289/ehp.10047.

    PMID: 17805417BACKGROUND
  • Krittanawong C, Johnson KW, Rosenson RS, Wang Z, Aydar M, Baber U, Min JK, Tang WHW, Halperin JL, Narayan SM. Deep learning for cardiovascular medicine: a practical primer. Eur Heart J. 2019 Jul 1;40(25):2058-2073. doi: 10.1093/eurheartj/ehz056.

    PMID: 30815669BACKGROUND
  • Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013 Jun 18;127(24):2436-41. doi: 10.1161/CIRCULATIONAHA.112.000298. Epub 2013 May 16.

    PMID: 23681066BACKGROUND

MeSH Terms

Conditions

Cardiovascular DiseasesHeart Failure

Condition Hierarchy (Ancestors)

Heart Diseases

Study Officials

  • Gilles Barone-Rochette

    CHU Grenoble Alpes

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gilles Barone-Rochette

CONTACT

Clémence Charlon

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2022

First Posted

April 7, 2022

Study Start

May 1, 2022

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

April 7, 2022

Record last verified: 2022-01